BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23570416)

  • 21. Expressions of melanoma-associated antigen A1 as a prognostic factor in Chinese patients with resectable oesophageal squamous cell carcinoma.
    Yu Y; Huang C; Li Z; Zhao F; Zhou Y; Li J; Zhu C; Li Q; Zhuang Y; Xu J; Luo J; Chen L; Wang W
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):510-516. PubMed ID: 31169876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
    Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
    Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma.
    Sui P; Hu P; Zhang T; Zhang X; Liu Q; Du J
    Med Oncol; 2014 Feb; 31(2):809. PubMed ID: 24338377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.
    Wang Z; He W; Yang G; Wang J; Wang Z; Nesland JM; Holm R; Suo Z
    BMC Cancer; 2010 Jul; 10():352. PubMed ID: 20602752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.
    You Z; Xu D; Ji J; Guo W; Zhu W; He J
    Clin Transl Oncol; 2012 Feb; 14(2):143-9. PubMed ID: 22301404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
    J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of SOX9 Is Related to Prognosis in Patients with Oesophageal Squamous Cell Carcinoma.
    Higo N; Okumura H; Uchikado Y; Omoto I; Sasaki K; Kita Y; Ryosuke D; Noda M; Owaki T; Ishigami S; Natsugoe S
    In Vivo; 2018; 32(4):835-838. PubMed ID: 29936467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
    Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients.
    Xie F; Li K; Ouyang X
    Clin Exp Metastasis; 2009; 26(8):1025-32. PubMed ID: 19816777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
    Sun ZG; Liu XY; Zhang M; Wang Z
    Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
    Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
    Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of subcarinal lymph node metastasis in patients with esophageal squamous cell carcinoma.
    Feng JF; Zhao Q; Chen QX
    Asian Pac J Cancer Prev; 2013; 14(5):3183-6. PubMed ID: 23803101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis.
    Zhong X; Chen X; Guan X; Zhang H; Ma Y; Zhang S; Wang E; Zhang L; Han Y
    Histopathology; 2015 Jan; 66(2):192-200. PubMed ID: 24805087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of KLK13 promotes the invasiveness and metastasis of oesophageal squamous cell carcinoma.
    Lin Q; Mao W; Wu Q; He X; Li S; Fan Y; Chen J; Feng T; Cao X
    Biomed Pharmacother; 2017 Dec; 96():1008-1015. PubMed ID: 29221724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD117 Expression in Squamous Cell Carcinoma of the Oesophagus.
    Moreira LF; Maino MM; Garbin HI; DA Natividade GR; Volkweis BS; Kulczynski JU
    Anticancer Res; 2018 Jul; 38(7):3929-3933. PubMed ID: 29970514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.